Skip to Content

Oxytrol for Women Approval History

  • FDA approved: Yes (First approved January 25th, 2013)
  • Brand name: Oxytrol for Women
  • Generic name: oxybutynin
  • Dosage form: Transdermal System
  • Company: Merck
  • Treatment for: Overactive Bladder

Oxytrol for Women (oxybutynin) is a muscarinic receptor antagonist transdermal patch available over-the-counter for the treatment of overactive bladder in women.

Development History and FDA Approval Process for Oxytrol for Women

Jan 25, 2013Approval FDA Approves Over-the-Counter Oxytrol for Women to treat Overactive Bladder

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.